Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Amoéba logo — @AmoebaNature

Amoéba

@AmoebaNature

Founded 2010 France France 31 employees Post Ipo Debt Total: $6.65M Biotechnology, Waste Solution

General Information

Company Name Amoéba
Founded Year 2010
Location France France +1
Employees 31
Industries Biotechnology, Waste Solution
Funding Stage Post Ipo Debt
Social

Get notified when Amoéba moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Amoéba

Amoéba, founded in 2010 and headquartered in France, is a pioneering entity in the field of industrial greentech, focusing on microbiological risk treatment for natural resources. Their groundbreaking solutions leverage the unique properties of the micro-organism Willaertia magna C2c Maky.

Amoéba offers diverse applications across industries. In cosmetics, their latest innovation provides anti-aging and UV protection benefits, confirmed by a 2024 clinical study and registered on the INCI list. Their agricultural product, AXPERA, utilizes antifungal properties for plant protection, with approvals from the US EPA in 2022 and positive European recommendations. BIOMEBA, targeting water treatment, has also received US EPA approval, setting it apart in industrial water treatment.

In July 2018, Amoéba secured a €6.00M Post-IPO Debt investment from Nice & Green SA. The firm continues to carve a niche in biotechnology and waste solutions, standing out as a promising investment opportunity.

Taxonomy: Cosmetic Innovation, Anti-Aging Solutions, UV Protection, Agricultural Biocontrol, Antifungal Technology, Biological Agriculture, Water Treatment, Biocide Solutions, Cooling Tower Maintenance, Microbiological Risk Management, Plant Protection, Green Biocide, Sustainable Skincare, Pathogen Control

Services & Products

Development of applications using Willaertia Magna C2c Maky
Microbiological risk prevention solutions
Research and development for eco-industrial applications
Fungicide and biocide production

Target Customers

Industrial partners in the environmental and health sectors Agricultural sectors requiring plant protection solutions Manufacturers in the water treatment industry Cosmetic companies for biotechnological applications

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1
Investor
26 Jul 2018
Series A •••••• 2
Investor Investor
01 Jul 2014

FAQ About Amoéba

@AmoebaNature
Amoéba was founded in 2010.
Amoéba is headquartered in France.
Amoéba operates in the following industries: Biotechnology, Waste Solution.
Amoéba has approximately 31 employees.
Amoéba has completed 2 funding rounds, raising a total of $6.65M. The latest funding stage is Post Ipo Debt.
Amoéba offers: Development of applications using Willaertia Magna C2c Maky, Microbiological risk prevention solutions, Research and development for eco-industrial applications, Fungicide and biocide production.

We're actively collecting intelligence on Amoéba .

Track Amoéba to get notified

Don't just browse. Track.

Signal Tracker monitors Amoéba and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy